Flossbach Von Storch
BNTX icon

Flossbach Von Storch’s BioNTech BNTX Stock Holding History

Flossbach Von Storch’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17M Sell
173,272
-2,052,866
-92% -$199M 0.09% 66
2026
Q2 		$207M Sell
2,226,138
-1,454,177
-40% -$137M 0.94% 32
2026
Q1 		$327M Sell
3,680,315
-515,733
-12% -$53M 1.53% 22
2025
Q4 		$399M Sell
4,196,048
-33,985
-0.8% -$3.42M 1.58% 21
2025
Q3 		$417M Sell
4,230,033
-65
-0% -$6.95K 1.64% 24
2025
Q2 		$450M Sell
4,230,098
-29,533
-0.7% -$2.98M 1.84% 21
2025
Q1 		$388M Sell
4,259,631
-147,212
-3% -$16.5M 1.68% 21
2024
Q4 		$502M Buy
4,406,843
+47,236
+1% +$5.39M 2% 20
2024
Q3 		$518M Sell
4,359,607
-19,876
-0.5% -$1.83M 2.03% 21
2024
Q2 		$352M Buy
4,379,483
+910,497
+26% +$83.2M 1.48% 20
2024
Q1 		$320M Sell
3,468,986
-79,674
-2% -$7.64M 1.39% 19
2023
Q4 		$375M Buy
3,548,660
+35,445
+1% +$3.57M 1.71% 19
2023
Q3 		$382M Buy
3,513,215
+71,468
+2% +$7.9M 1.68% 21
2023
Q2 		$371M Buy
3,441,747
+9,413
+0.3% +$1.06M 1.5% 21
2023
Q1 		$428M Buy
3,432,334
+149,611
+5% +$20.5M 1.8% 21
2022
Q4 		$493M Sell
3,282,723
-81,841
-2% -$12.6M 1.88% 26
2022
Q3 		$454M Buy
3,364,564
+299,414
+10% +$45.8M 1.67% 29
2022
Q2 		$457M Buy
3,065,150
+1,145,061
+60% +$175M 1.53% 30
2022
Q1 		$327M Buy
+1,920,089
New +$323M 0.91% 35

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Davern Capital Partners
Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return

Flossbach Von Storch's BNTX Position: Q3 2026 in Review

Flossbach Von Storch reduced its BioNTech (BNTX) stake by 92% in Q3 2026, selling an estimated $199M and leaving 173,272 shares worth $17M. The position accounts for 0.09% of the portfolio, ranked #66.

Flossbach Von Storch first reported a position in BNTX in Q1 2022 and has held it in 19 quarters since. The position peaked at $518M in Q3 2024. 223 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Flossbach Von Storch held 173,272 shares of BioNTech worth $17M as of Q3 2026.
  • Flossbach Von Storch sold 2,052,866 BioNTech shares in Q3 2026, an estimated $199M.
  • BioNTech made up 0.09% of Flossbach Von Storch's portfolio in Q3 2026, its #66 holding.
  • Flossbach Von Storch first reported a position in BioNTech in Q1 2022 and has held it in 19 quarters since.
  • Flossbach Von Storch's BioNTech position peaked at $518M in Q3 2024.
  • 223 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Flossbach Von Storch's 13F filing for Q3 2026, filed 28 Oct 2026.